Katrina Abuabara, MD, FAAD
SESSIONS
No sessions scheduled for this speaker.
DISCLOSURES
Amgen – Consultant (1099 relationship)(Fees); Cedar Healthcare – Stockholder(Stock); Cosmetique – Investigator(Grants/Research Funding); Healthpilot – Stockholder(Stock Options); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Picwell Inc. – Board of Directors(Stock); TARGET Pharma – Advisory Board(Fees);